| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer
|
Day, Fiona
|
|
2014
|
10 |
1 |
p. 99-109
|
article
|
| 2 |
An observational cohort study of bevacizumab and chemotherapy in metastatic colorectal cancer patients: safety and efficacy with analysis by age group
|
Tahover, Esther
|
|
2014
|
10 |
1 |
p. 55-63
|
article
|
| 3 |
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab
|
Tabernero, Josep
|
|
2014
|
10 |
1 |
p. 65-76
|
article
|
| 4 |
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
|
Brana, Irene
|
|
2014
|
10 |
1 |
p. 111-123
|
article
|
| 5 |
Early skin toxicity predicts better outcomes, and early tumor shrinkage predicts better response after cetuximab treatment in advanced colorectal cancer
|
Kogawa, T.
|
|
2014
|
10 |
1 |
p. 125-133
|
article
|
| 6 |
Erlotinib in combination with pemetrexed/cisplatin for leptomeningeal metastases and cerebrospinal fluid drug concentrations in lung adenocarcinoma patients after gefitinib faliure
|
Yang, Haihong
|
|
2014
|
10 |
1 |
p. 135-140
|
article
|
| 7 |
Expression and activity of EGFR in human cutaneous melanoma cell lines and influence of vemurafenib on the EGFR pathway
|
Gross, Alexander
|
|
2014
|
10 |
1 |
p. 77-84
|
article
|
| 8 |
Gefitinib: a review of its use in adults with advanced non-small cell lung cancer
|
Dhillon, Sohita
|
|
2015
|
10 |
1 |
p. 153-170
|
article
|
| 9 |
Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial
|
Rini, Brian I.
|
|
2014
|
10 |
1 |
p. 45-53
|
article
|
| 10 |
Idelalisib: a review of its use in chronic lymphocytic leukaemia and indolent non-Hodgkin’s lymphoma
|
Keating, Gillian M.
|
|
2015
|
10 |
1 |
p. 141-151
|
article
|
| 11 |
QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive review
|
Locatelli, Marzia
|
|
2014
|
10 |
1 |
p. 27-43
|
article
|
| 12 |
Sorafenib: a review of its use in patients with radioactive iodine-refractory, metastatic differentiated thyroid carcinoma
|
Blair, Hannah A.
|
|
2015
|
10 |
1 |
p. 171-178
|
article
|
| 13 |
Study on mouse model of triple-negative breast cancer: association between higher parity and triple-negative breast cancer
|
Huang, Chun
|
|
2014
|
10 |
1 |
p. 85-97
|
article
|
| 14 |
The status of radioimmunotherapy in CD20+ non-Hodgkin’s lymphoma
|
Read, Evan D.
|
|
2014
|
10 |
1 |
p. 15-26
|
article
|
| 15 |
Transforming growth factor-beta and its implication in the malignancy of gliomas
|
Roy, Laurent-Olivier
|
|
2014
|
10 |
1 |
p. 1-14
|
article
|
Journal description